Skip to content

Reverse Shoulder Prosthesis Prospective Multi-Center Study

PS-901: Prospective Multicenter Open Label Study of the Encore Reverse® Shoulder Prosthesis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01005446
Enrollment
245
Registered
2009-11-02
Start date
2009-12-31
Completion date
2018-06-30
Last updated
2021-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Failed Shoulder Replacement, Rotator Cuff Deficiency, Shoulder Arthropathy

Brief summary

The purpose of this study is to evaluate the use and efficacy of the Reverse® Shoulder Prosthesis for treatment of rotator cuff deficiency in subjects who are candidates for a total shoulder replacement (primary and revision subjects).

Detailed description

Reverse shoulder arthroplasty for the treatment of rotator cuff deficiency and glenohumeral arthritis have shown favorable outcomes in pain and function over the short and medium term. A prospective, multi-center study on the outcomes of subjects treated with the RSP would be a valuable addition to the literature and give important information regarding an ever-increasing treatment option for subjects with rotator cuff deficiency. The study will take place at multiple sites across the United States and will be managed by the DJO Surgical Clinical Affairs Department. The study will include only subjects who meet the indications for use criteria for the Reverse® Shoulder Prosthesis and who are candidates for total shoulder replacement surgery.

Interventions

DEVICEEncore Reverse Shoulder Prosthesis (RSP®)

The RSP is indicated for use in subjects with grossly rotator cuff deficient shoulder joints with severe arthropathy or a previously failed joint replacement with a grossly rotator cuff deficient shoulder joint.

Sponsors

DJO Incorporated
CollaboratorINDUSTRY
Encore Medical, L.P.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject must be a candidate for a total shoulder joint replacement * Subject must be diagnosed with one or more of the following conditions: Irreparable rotator cuff tear with gleno-humeral arthritis; Failed rotator cuff surgery with gleno-humeral instability or antero- superior escape; Failed shoulder replacement surgery * Subject has a functional deltoid muscle * Subject's joint must be anatomically and functionally suited to receive the selected implant * Subject is 60 years of age or older (≥ 60 yrs of age) at time of consent * Subject is likely to be available for all study visits * Subject is able and willing to sign the informed consent and follow study procedures * Subject is not pregnant

Exclusion criteria

* Subject has a non-functional deltoid muscle * Subject has a mental condition(s) that may interfere with the subject's ability to give an informed consent or willingness to fulfill the study requirements (i.e., severe mental retardation such that the Subject cannot understand the informed consent process, global dementia, prior strokes that interfere with the Subject's cognitive abilities, senile dementia, and Alzheimer's Disease) * Subject is a prisoner * Subject has high levels of physical activity (ex. competitive sports, heavy physical labor) * Subject is pregnant * Subject has an active infection or sepsis * Subject has loss of ligamentous structures * Subject has a history of alcoholism or other addictions (current or past) * Subject has muscular, neurological or vascular deficiencies which compromise the affected extremity (i.e., Parkinson's Disease, Syringomyelia and Multiple Sclerosis, Charcot joints) * Subject has severe glenoid bone loss * Subject has known materials sensitivity (to metals) * Subject is younger than 60 years of age (\< 60 years of age) at consent

Design outcomes

Primary

MeasureTime frameDescription
Improvement in American Shoulder and Elbow Surgeons Score (ASES) from Baseline2 yearImprovement in American Shoulder and Elbow Surgeons Score (ASES) from Baseline. Assessments include: 1) Pain score where 0=no pain at all and 10=pain as bad as it can be 2) Function score where 0=my should is useless and 10=my shoulder is normal 3) Activity score where 0=unable to do and 3=Normal.

Secondary

MeasureTime frameDescription
Subject Satisfaction Survey5 yearPatient Related Outcome of Device Satisfaction (score 1-5 with 1 = best and 5 = worst) Device satisfaction
Radiologic Success5 yearChanges in radiolucency compared with Baseline
Change in ASES score from Baseline5 yearImprovement in American Shoulder and Elbow Surgeons Score (ASES) from Baseline. Assessments include: 1) Pain score where 0=no pain at all and 10=pain as bad as it can be 2) Function score where 0=my should is useless and 10=my shoulder is normal 3) Activity score where 0=unable to do and 3=Normal.
SF36- (Short Form 36)Health Survey5 yearChange from baseline using the SF36-Health Status. There are multiple scales for general health, pain and activities of daily living
Change in Simple Shoulder Test from Baseline5 yearChange in Simple Shoulder Test from Baseline. Twelve questions about pain and functionality with responses being yes or no

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026